Your browser doesn't support javascript.
loading
Effect of Genetic Variation in CYP450 on Gonadal Impairment in a European Cohort of Female Childhood Cancer Survivors, Based on a Candidate Gene Approach: Results from the PanCareLIFE Study.
van der Perk, M E Madeleine; Broer, Linda; Yasui, Yutaka; Robison, Leslie L; Hudson, Melissa M; Laven, Joop S E; van der Pal, Helena J; Tissing, Wim J E; Versluys, Birgitta; Bresters, Dorine; Kaspers, Gertjan J L; de Vries, Andrica C H; Lambalk, Cornelis B; Overbeek, Annelies; Loonen, Jacqueline J; Beerendonk, Catharina C M; Byrne, Julianne; Berger, Claire; Clemens, Eva; Dirksen, Uta; Winther, Jeanette Falck; Fosså, Sophie D; Grabow, Desiree; Muraca, Monica; Kaiser, Melanie; Kepák, Tomás; Kruseova, Jarmila; Modan-Moses, Dalit; Spix, Claudia; Zolk, Oliver; Kaatsch, Peter; Krijthe, Jesse H; Kremer, Leontien C M; Brooke, Russell J; Baedke, Jessica L; van Schaik, Ron H N; van den Anker, John N; Uitterlinden, André G; Bos, Annelies M E; van Leeuwen, Flora E; van Dulmen-den Broeder, Eline; van der Kooi, Anne-Lotte L F; van den Heuvel-Eibrink, Marry M.
Afiliação
  • van der Perk MEM; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Broer L; Department of Internal Medicine, Rotterdam, ErasmusMC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • Yasui Y; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Robison LL; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Hudson MM; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • Laven JSE; Department of Oncology, Division of Survivorship, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • van der Pal HJ; Department of Obstetrics and Gynecology, Erasmus MC-University Medical Center, 3015 GD Rotterdam, The Netherlands.
  • Tissing WJE; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Versluys B; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Bresters D; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Kaspers GJL; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • de Vries ACH; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Lambalk CB; Department of Pediatric Oncology-Haematology, Emma Children's Hospital, Amsterdam UMC, Vrije Universiteit Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Overbeek A; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Loonen JJ; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Beerendonk CCM; Department of Obstetrics and Gynaecology, Amsterdam UMC, Vrije Universiteit Amsterdam, 1105 AZ Amsterdam, The Netherlands.
  • Byrne J; Department of Haematology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Berger C; Department of Obstetrics and Gynaecology, Radboud University Medical Center, 6500 HB Nijmegen, The Netherlands.
  • Clemens E; Boyne Research Institute, 5 Bolton Square, East, Drogheda, A92 RY6K Co. Louth, Ireland.
  • Dirksen U; Department of Paediatric Oncology, University Hospital, 42 055 Saint-Etienne, France.
  • Winther JF; Lyon University, Jean Monnet University, INSERM, U 1059, Sainbiose, 42023 Saint-Etienne, France.
  • Fosså SD; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Grabow D; University Hospital Essen, Pediatrics III, West German Cancer Centre, 45147 Essen, Germany.
  • Muraca M; German Cancer Research Centre, DKTK, Site Essen, 45147 Essen, Germany.
  • Kaiser M; Childhood Cancer Research Group, Danish Cancer Society Research Center, 2100 Copenhagen, Denmark.
  • Kepák T; Department of Clinical Medicine, Faculty of Health, Aarhus University and University Hospital, 8200 Aarhus, Denmark.
  • Kruseova J; Department of Oncology, Oslo University Hospital, 0372 Oslo, Norway.
  • Modan-Moses D; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Spix C; Epidemiology and Biostatistics Unit and DOPO Clinic, IRCCS Istituto Giannina Gaslini, 16147 Genova, Italy.
  • Zolk O; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Kaatsch P; University Hospital Brno, International Clinical Research Center (FNUSA-ICRC), Masaryk University, 656 91 Brno, Czech Republic.
  • Krijthe JH; Motol University Hospital, 150 05 Prague, Czech Republic.
  • Kremer LCM; The Edmond and Lily Safra Children's Hospital, Chaim Sheba Medical Center, Tel Hashomer, and the Sackler Faculty of Medicine, Tel-Aviv University, Tel-Aviv 6997801, Israel.
  • Brooke RJ; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • Baedke JL; Institute of Clinical Pharmacology, Brandenburg Medical School Theodor Fontane, Immanuel Klinik Rüdersdorf, 16816 Neuruppin, Germany.
  • van Schaik RHN; Division of Childhood Cancer Epidemiology, German Childhood Cancer Registry, Institute of Medical Biostatistics, Epidemiology and Informatics (IMBEI), University Medical Center of the Johannes Gutenberg University Mainz, 55131 Mainz, Germany.
  • van den Anker JN; Department of Intelligent Systems, Delft University of Technology, 2628 BL Delft, The Netherlands.
  • Uitterlinden AG; Princess Máxima Center for Pediatric Oncology, 3584 CS Utrecht, The Netherlands.
  • Bos AME; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • van Leeuwen FE; Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN 38105, USA.
  • van Dulmen-den Broeder E; Department of clinical chemistry, Erasmus MC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • van der Kooi ALF; Division of Clinical Pharmacology, Children's National Hospital, Washington, DC 20010, USA.
  • van den Heuvel-Eibrink MM; Department of Internal Medicine, Rotterdam, ErasmusMC University Medical Center Rotterdam, 3015 GD Rotterdam, The Netherlands.
  • On Behalf Of The PanCareLIFE Consortium; Department of Reproductive Medicine and Gynecology, University Medical Center Utrecht, 3584 CS Utrecht, The Netherlands.
Cancers (Basel) ; 13(18)2021 09 13.
Article em En | MEDLINE | ID: mdl-34572825
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Cancers (Basel) Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Holanda